Inhibition and induction of human cytochrome P450 enzymes: current status.
about
Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver diseasePharmacokinetic drug interactions in liver disease: An updatePharmacokinetic interactions of herbs with cytochrome p450 and p-glycoproteinPredicting drug-target interaction networks based on functional groups and biological featuresA unified proteochemometric model for prediction of inhibition of cytochrome p450 isoformsUp-regulating CYP3A4 expression in C3A cells by transfection with a novel chimeric regulator of hPXR-p53-ADComputational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanismsCardiac safety of ophthalmic timolol.Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Inhibition of Carcinogen-Activating Cytochrome P450 Enzymes by Xenobiotic Chemicals in Relation to Antimutagenicity and Anticarcinogenicity.Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activatorEffects of nicotine on cytochrome P450 2A6 and 2E1 activities.Epidemiology of idiosyncratic drug-induced liver injuryPreliminary investigation of the contribution of CYP2A6, CYP2B6, and UGT1A9 polymorphisms on artesunate-mefloquine treatment response in Burmese patients with Plasmodium falciparum malaria.Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.Evaluation of metabolism-mediated herb-drug interactions.Cytochrome P450 induction properties of food and herbal-derived compounds using a novel multiplex RT-qPCR in vitro assay, a drug-food interaction prediction toolPrediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug-like Molecules.Sucralose, a synthetic organochlorine sweetener: overview of biological issuesMolecular mechanisms of the microsomal mixed function oxidases and biological and pathological implicationsEffects of eleutheroside B and eleutheroside E on activity of cytochrome P450 in rat liver microsomes.In silico toxicology - non-testing methods.Pathway-Targeted Pharmacogenomics of CYP1A2 in Human Liver.Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.Clinically relevant drug-drug interactions between antiretrovirals and antifungalsEffects of brown rice and white rice on expression of xenobiotic metabolism genes in type 2 diabetic rats.A population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.Development of NanoART for HIV Treatment: Minding the Cytochrome P450 (CYP) EnzymesPharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevanceMolecular mechanisms underlying chemical liver injury.Effects of ospemifene on drug metabolism mediated by cytochrome P450 enzymes in humans in vitro and in vivo.Antiretroviral drug interactions: overview of interactions involving new and investigational agents and the role of therapeutic drug monitoring for management.Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models.The effect of piperine on midazolam plasma concentration in healthy volunteers, a research on the CYP3A-involving metabolism.Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation.QSAR of cytochrome inhibitors.Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.Drug interactions with antiretrovirals and warfarin.Ambient tonicity and intestinal cytochrome CYP3A.Sources of variability in ketoconazole inhibition of human cytochrome P450 3A in vitro.
P2860
Q24319917-76D6B618-69B7-4778-88F9-D08FD1733A22Q26774479-D2E8E53C-636C-41D8-A3C9-6265F4A4E6C4Q28087178-7052B808-D79F-4797-885F-8E401BF6F81EQ28473160-1A6869BD-59D3-4FF6-8DAF-806A42A8C134Q28533964-5A077C44-1536-4416-8B23-3241F2CE254FQ28538313-580EBA03-21A2-4E87-A458-9F7DFC6A300EQ28730803-96467C83-7D15-4844-B684-D692686CF9BDQ33167596-C0BB1E46-63C0-4F90-8250-296DDE9CCEFFQ33509452-F4549CAD-57B9-4174-B95E-6804B207E39DQ33596274-8B7C0045-AF79-4776-84E0-E9578485BDFBQ33606444-F4886427-DDD8-4771-BDAE-F5A6A9103D67Q33668208-684C342B-3640-4BFD-BAD4-EF382CC793F3Q33990236-801CE664-BF4B-4BF4-B40E-750DCD1D982AQ34015980-6CCEFC9C-7698-43D0-873E-0AEB34B49EADQ34181630-3E25FC9A-2C2B-4F56-BBDD-7992CD19FA3BQ34238039-DCCE7679-0C61-4089-810E-B5D58641C49BQ34542725-35DACA07-8DE9-475E-83CA-ADE0C39777E4Q34608018-537332BE-F34E-45AF-9E5E-1AEA72EBC40CQ34657381-AE3716FE-840F-4C80-8776-AA22F5DB1CFCQ35024501-3E0A9D5D-2C3A-4F30-8B86-E2F15F346033Q35079548-C0770087-FB2B-4A08-BEED-DB302D570F1AQ35084668-F4D3AE8C-5633-4DEC-BDB3-613CF6F9AE1AQ35210306-888D7F9A-47E7-4C0A-8606-8589513859B1Q35609358-2B22CF88-F2B4-4F9C-B238-5BE77592B22DQ35892563-89FFFAA9-DC40-42E3-ABF5-9D7B1BEE8A9FQ36197269-91E74E09-67E2-493C-9323-4FEAF7E5390AQ36203546-F19DA3A9-0698-4B5A-9FA9-C94AFDA353AFQ36338109-728EDBFD-3240-4F34-A255-D9B57CF6EBC5Q36657589-31E72316-911A-487D-887F-C404D05B7BFAQ36991523-BA560C2E-E942-42F1-99A0-22B9EA2FC095Q37091899-4AC83424-80F9-4651-980D-DCD52294B3A8Q37378110-00A5677E-641E-4050-8783-8CA251D283DBQ37521097-CA5468E9-0A48-4F6F-B1D9-97F263C43991Q37523782-F21B0F8E-7FD3-470D-ACC2-EA763488D6E7Q37557621-1BE17A4F-B385-4310-847C-0C58222A9DA4Q37587216-B25D95FF-E76D-41C5-9765-6CF6CD88DDBBQ37640084-C3014049-307A-4AE4-87CA-9E532ED3C7E6Q37679935-06B5655A-A6D7-4138-AE4E-57FF5EC7EB44Q37725997-C787E641-D717-418D-B150-233AA38BD10BQ37780212-E54D768E-EFF4-43C8-808C-FB55532A7893
P2860
Inhibition and induction of human cytochrome P450 enzymes: current status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition and induction of human cytochrome P450 enzymes: current status.
@en
Inhibition and induction of human cytochrome P450 enzymes: current status.
@nl
type
label
Inhibition and induction of human cytochrome P450 enzymes: current status.
@en
Inhibition and induction of human cytochrome P450 enzymes: current status.
@nl
prefLabel
Inhibition and induction of human cytochrome P450 enzymes: current status.
@en
Inhibition and induction of human cytochrome P450 enzymes: current status.
@nl
P2093
P2860
P1476
Inhibition and induction of human cytochrome P450 enzymes: current status.
@en
P2093
Hannu Raunio
Janne Hukkanen
Jukka Hakkola
Miia Turpeinen
Olavi Pelkonen
Paavo Honkakoski
P2860
P2888
P304
P356
10.1007/S00204-008-0332-8
P577
2008-07-11T00:00:00Z